Form 8-K - Current report:
SEC Accession No. 0000950170-21-004851
Filing Date
2021-11-23
Accepted
2021-11-22 19:30:38
Documents
16
Period of Report
2021-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pali-20211118.htm   iXBRL 8-K 108458
2 EX-10.1 pali-ex10_1.htm EX-10.1 346762
3 EX-10.4 pali-ex10_4.htm EX-10.4 123995
4 EX-10.5 pali-ex10_5.htm EX-10.5 112752
5 EX-10.6 pali-ex10_6.htm EX-10.6 345754
  Complete submission text file 0000950170-21-004851.txt   1281660

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pali-20211118_lab.xml EX-101.LAB 13466
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pali-20211118.xsd EX-101.SCH 2496
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pali-20211118_pre.xml EX-101.PRE 9906
9 EXTRACTED XBRL INSTANCE DOCUMENT pali-20211118_htm.xml XML 4733
Mailing Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008
Business Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 211434237
SIC: 2836 Biological Products, (No Diagnostic Substances)